Google

Push Security is a cybersecurity software company focused on protecting identities and preventing identity-based attacks. It provides a browser-based agent that observes how employees use and create identities, generating telemetry that can be viewed in the Push platform or forwarded to SIEM or SOAR systems. The software enables security teams to monitor and secure the entire identity attack surface and detect and block identity-based threats, including advanced phishing techniques. It enforces in-browser controls to block, warn, or guide employees to prevent breaches. The solution also offers clear, step-by-step guidance on implementing essential security controls and uses automation to accelerate deployment, helping organizations improve security without adding costly tools or complex deployments.

Omni is a technology company specializing in business intelligence platforms. It offers a unique solution that combines the consistency of a shared data model with the flexibility of SQL, enabling users to efficiently analyze and share reliable metrics while avoiding unnecessary complexity.

Blockaid is a technology company that specializes in digital security. It develops a security platform designed to safeguard users from fraud, phishing, and hacks. The company employs a range of security features, including blockchain technology, to ensure the safety and security of users' data. This enables online businesses to offer their services with confidence, knowing that their customers' data is protected.

Allara Health is a healthcare provider specializing in virtual care for women facing complex, chronic health conditions, particularly polycystic ovary syndrome (PCOS). The company offers a comprehensive program that connects patients with medical providers and registered dietitians through virtual appointments. Allara's services include holistic care, diagnostic testing, and prescriptions, along with personalized guidance on dietary and lifestyle changes. By leveraging technology, the platform enables women to efficiently manage their health, allowing for improved tracking and treatment of their conditions.

Leyden Labs develops a Mucosal Protection Platform to protect against respiratory viruses, including influenza and coronaviruses. The company offers a portfolio of broad protective nasal sprays designed to reduce the risk of infection and limit transmission, aiming to improve public health through innovative protection methods. Its team combines biotechnology veterans with new talent to advance solutions that address common viral threats at the mucosal surface.

Founded in 2019, Roboflow develops software tools that empower software engineers to build computer vision applications more efficiently. Its platforms, including Roboflow Organize and Roboflow Pro, streamline dataset management, offer insights, enable image transformations, facilitate integrations, and allow sharing, thereby accelerating the development process.

Vitara Biomedical is focused on developing a therapeutic platform designed to support premature infants. The company draws inspiration from natural physiological processes to improve neonatal care, aiming to enhance the quality of life for these vulnerable newborns. By addressing the unique challenges faced by premature infants, Vitara Biomedical seeks to reduce mortality rates and associated health complications, ultimately providing a foundation for a healthier future for both infants and their families.

Metsera is a clinical-stage biopharmaceutical company specializing in developing innovative therapies for obesity and metabolic conditions. It focuses on advancing oral and injectable treatments, integrating proprietary health technology tools for personalized care.

PeopleOne Health delivers advanced healthcare solutions that integrate treatment and prevention, resulting in substantial cost savings for employers (up to 30%) and improved employee recruitment/retention. Employees enjoy complimentary access to top-tier doctors and healthcare professionals, with a focus on comprehensive primary care and mental health support.

Scope3 provides a supply chain emissions data platform that serves as the source of truth for corporate greenhouse gas information. The company models the core inputs and outputs of products and services across the supply chain, designs systems to reduce environmental impact, and produces monthly sustainability reports that update with fresh data. This enables organizations to factor emissions into business decisions, respond rapidly to changes, and receive recognition for investments in reducing their carbon footprint.

Mechanical Orchard is a technology company based in San Francisco that specializes in modernizing and managing critical business applications for large enterprises. By de-risking the process of updating legacy computer systems, the company helps its clients remain competitive in a rapidly evolving marketplace. Mechanical Orchard focuses on developing custom applications for cloud operations, employing advanced product development, software engineering, and DevOps practices to address complex challenges. The firm aims to ensure that businesses can run secure, reliable, and scalable applications, enabling them to stay ahead of the curve in their respective industries.

Cardurion Pharmaceuticals, LLC, established in 2017 and headquartered in Boston, Massachusetts, is a biotechnology company dedicated to developing innovative therapies for heart failure and other cardiovascular diseases. The company is advancing clinical programs that target PDE9 and CaMKII inhibition, utilizing its expertise in cardiovascular signaling pathways to address significant unmet patient needs.

Founded in 2020, Hebbia develops AI productivity tools for knowledge workers. Its platform breaks down complex tasks into manageable steps, enabling professionals across finance, law, and other sectors to efficiently process large volumes of documents using generative models.

Santa Ana Bio is a biotechnology company specializing in the development of precision immunology therapies for autoimmune diseases. It employs advanced multi-omics platforms and antibody engineering techniques to design targeted biologics, aiming to improve patient outcomes and quality of life.

Cerevance develops novel therapeutics for neurological disorders such as Alzheimer's disease, Parkinson's disease, and other chronic neurodegenerative conditions. It uses a proprietary platform to profile specific brain cell types in human tissue samples, enabling the identification of promising targets for new treatments.

Midi Health is a virtual care clinic specializing in women's health. It offers personalized treatment protocols for depression, gynecological cancer, and menstrual issues, delivered by clinicians trained in female midlife health. The platform leverages at-home labs, prescription medications, supplements, and lifestyle coaching to provide comprehensive care.

Alethea is a technology company helping the Fortune 500, private companies and nonprofits protect themselves from harms stemming from disinformation. Leveraging its multi-channel machine learning platform, Artemis, Alethea detects disinformation narratives across the internet, enabling customers to proactively defend against this pervasive threat. With Artemis-powered early detection, Alethea customers can protect their reputations, key assets, physical safety and market value. The company was founded in 2019 and is woman owned.

Oula Health, Inc. is a maternity care provider based in Brooklyn, New York, established in 2019. The company focuses on redesigning maternity care by integrating obstetrics and midwifery to create a personalized and evidence-based experience for expecting families. Oula operates clinics and offers home-based prenatal care services, aiming to set a new standard for pregnancy care that harmonizes modern medical practices with a compassionate approach. Through its innovative model, Oula Health seeks to enhance the overall maternity care experience for its clients.

Comanche is a biopharmaceutical company developing an investigational siRNA medicine for preterm preeclampsia. Its mission is to provide safe, effective, evidence-based, and affordable therapies for treating life-threatening complications of pregnancy.

Seismic Therapeutic is a biotechnology company focused on advancing immunology drug development through the integration of machine learning in the biologics discovery process. Utilizing its proprietary IMPACT™ platform, Seismic Therapeutic addresses critical challenges in the development of biologics by combining machine learning with structural biology, protein engineering, and translational immunology. This innovative approach aims to create optimized therapies for patients more efficiently. The company is developing a pipeline of biologics specifically targeting adaptive immune system dysregulation to treat various autoimmune diseases.

Signos is a health technology company focused on addressing the obesity epidemic by promoting healthy habits and stabilizing glucose levels through innovative solutions. The company offers a weight loss application that leverages continuous glucose monitoring in conjunction with an AI-enhanced platform. This combination provides users with real-time data and personalized recommendations for meals and exercises tailored to their unique metabolic responses. By enabling individuals to better understand their body's reactions to food, Signos aims to facilitate effective weight loss and foster sustainable health improvements. With a significant portion of the American population facing weight-related challenges, Signos presents a modern approach to support users on their journey towards healthier living.

Scope3 provides a supply chain emissions data platform that serves as the source of truth for corporate greenhouse gas information. The company models the core inputs and outputs of products and services across the supply chain, designs systems to reduce environmental impact, and produces monthly sustainability reports that update with fresh data. This enables organizations to factor emissions into business decisions, respond rapidly to changes, and receive recognition for investments in reducing their carbon footprint.

ROME Therapeutics, Inc. is a biotechnology company based in Cambridge, Massachusetts, focused on developing innovative therapies for cancer and autoimmune diseases. Founded in 2019, the company utilizes the repeatome, which encompasses extensive segments of genetic material previously regarded as "junk DNA," to identify new drug targets and advance multiple discovery programs. ROME Therapeutics has assembled a team of experts in oncology, immunology, virology, and machine learning to drive its research and development efforts, aiming to harness this uncharted area of biology for effective treatments. Through its work, ROME seeks to provide healthcare professionals with powerful new options for addressing complex medical challenges.

Modular is an artificial intelligence software development platform that aims to streamline the development and deployment of AI technologies. The company focuses on creating a user-friendly environment that enhances the speed and efficiency of developers by providing a unified interface for popular AI frameworks. Its platform is designed to support a variety of hardware backends and cloud environments, facilitating easy integration into existing workflows without the need for significant code rewrites or architectural changes. By combining high-quality infrastructure with a focus on usability and flexibility, Modular seeks to empower developers to work more effectively, ultimately accelerating the advancement of AI solutions across diverse applications.

Deepset is a technology company that specializes in natural language processing (NLP) solutions, providing tools and frameworks for enterprise AI teams. Established in 2018, the company is known for its Haystack open-source framework, which facilitates the development of NLP applications. Deepset's software leverages advancements in machine learning and transfer learning to enable users to extract value from diverse text sources and create customized models with reduced training data requirements. Through its offerings, deepset has supported numerous AI teams worldwide in applying cutting-edge NLP technologies to practical, real-world challenges. Additionally, the company provides deepset Cloud, an LLM platform that enhances collaboration and efficiency for enterprises focused on AI development.

Typeface is a generative AI application for creating enterprise content. It enables organizations to accelerate the production of on-brand content by combining speed, brand personalization, and governance across the content lifecycle. The platform offers self-service content development tools that cover the entire lifecycle, enabling employees to craft content with ease, speed, and brand authenticity while maintaining consistency. Typeface provides proactive suggestions to improve content and helps enterprises uphold brand standards as content scales across teams.

Warp is a developer of a Rust-based coding terminal aimed at enhancing productivity in coding and application development. Its software innovatively transforms the traditional command-line interface by dividing the terminal output into a sequence of commands, rather than presenting it as a single buffer. This approach replaces the standard character buffer with a comprehensive text editor, allowing software developers to efficiently navigate, copy, save, and share their work. Warp's terminal redefines the user experience by evolving from a single-user utility into a collaborative platform, where sessions, blocks, and environments are persistent, searchable, and easily shared via links.

Pixxel is space data company that develops hyperspectral earth-imaging satellite constellations to provide global coverage, capturing geospatial data for applications such as climate monitoring, crop yield prediction, urban planning, and disaster response. The constellation aims to deliver near-daily imagery, enabling detection, monitoring, and prediction of global phenomena. The company also offers satellites as a service, allowing clients to access and operate imaging assets to monitor changing environmental, economic, and security conditions. Founded in 2018 and headquartered in Bengaluru, India.

Chroma Medicine is a genomic medicine company founded in 2021 and based in Cambridge, Massachusetts, specializing in epigenetic editing. The company is pioneering a new class of genomic therapies aimed at revolutionizing the treatment of genetically driven diseases. By utilizing epigenetics, which is the natural mechanism for gene regulation, Chroma Medicine develops programmable epigenetic editors that target specific genes and modulate chromatin conformation. This innovative approach enables healthcare providers to achieve precise control of gene expression, offering a promising therapeutic option for conditions linked to genetic anomalies.

Aera Therapeutics is a biotechnology company focused on advancing genetic medicines through its proprietary protein nanoparticle (PNP) delivery platform. This innovative platform utilizes endogenous human proteins derived from retroelements, which self-assemble into capsid-like structures capable of packaging and transferring nucleic acid cargo. By addressing the limitations of current delivery technologies, Aera aims to enhance the efficacy and reach of genetic therapies across various tissues and disease areas. Additionally, the company holds a licensed technology that features a therapeutic enzyme platform based on novel, compact, and programmable gene-editing enzymes, further expanding its capabilities in the field of genetic medicine.

Cerevance develops novel therapeutics for neurological disorders such as Alzheimer's disease, Parkinson's disease, and other chronic neurodegenerative conditions. It uses a proprietary platform to profile specific brain cell types in human tissue samples, enabling the identification of promising targets for new treatments.

Pangea is a developer of security APIs that offers a comprehensive portfolio of security services tailored for application builders. The company provides a single platform that simplifies the integration of security into cloud and mobile applications. Pangea's services are designed to be globally accessible while maintaining regional intelligence, making them suitable for diverse markets. Available on major cloud platforms such as AWS and GCP, Pangea enables clients—including app developers, SaaS providers, and security operations teams—to efficiently create secure and compliant user experiences. The company aims to make security accessible to all developers, eliminating the need for extensive security expertise.

Dandelion Energy, Inc. is a Palo Alto, California-based company founded in 2017 that specializes in affordable geothermal heating and cooling solutions. The company replaces traditional air conditioning and heating systems with an innovative home geothermal system that utilizes a powerful heat pump and underground pipes to transfer heat between the earth and the residence. This system is designed to harness thermal energy from below the earth's surface to regulate indoor temperatures and provide hot water, allowing homeowners to transition from conventional heating fuels to a more sustainable geothermal alternative. Dandelion Energy is committed to making renewable heating and cooling accessible and cost-effective for homeowners.

Founded in 2018, Landis is a real estate technology company based in New York. It specializes in helping renters become homeowners by allowing customers to select their dream home, rent it initially, and purchase it anytime within the first twelve months. The company also assists customers in building credit and saving for a down payment, providing a transparent process for transitioning from renting to owning.

Altana Technologies is a company that specializes in transforming both public and non-public data into an intelligent, interconnected map of the global supply chain. By utilizing its platform, Altana Atlas, the company enables enterprises, governments, and logistics providers to connect and collaborate, fostering trust and transparency across business networks. The platform offers comprehensive trade data management services by integrating internal and external data, providing clean data sets, and delivering real-time insights related to transactions, ownership, movements, and risks in the global trade network. Through advanced machine learning techniques, Altana Technologies equips organizations across various sectors with the tools to enhance the safety, efficiency, and profitability of trade, contributing to a more resilient, secure, and sustainable approach to globalization.

Adda247 is an edtech platform based in Gurugram, India, specializing in the preparation for government examinations. Founded in 2010, the company provides a comprehensive learning ecosystem that includes online courses, study materials, and test series for various competitive exams. As a subsidiary of Metis Eduventures Private Limited, Adda247 aims to empower students with the resources needed to succeed in their academic and career pursuits in the public sector. The platform leverages technology to deliver accessible and effective educational solutions, making it a prominent player in the Indian education landscape.

Flatfile is a data onboarding platform that enables developers to validate, map, and import customer data from spreadsheets into software applications. It embeds a JavaScript snippet to add an import button in web apps and provides a secure Concierge workspace for collaboration to manage data ingestion. The platform supports CSV, XLS, and TSV uploads, allows users to configure a target model for data validation, and learns over time to improve accuracy. It is API-first and widely adopted by hundreds of companies, including AstraZeneca, Square, and Sage.

Sardine is a financial technology company that specializes in providing a risk and fraud infrastructure tailored for the online economy. It has developed a device intelligence platform that leverages artificial intelligence and advanced risk engine software. This platform enhances fraud detection while minimizing sign-up friction by analyzing multiple real-time data points, including device information, browser details, and behavioral biometrics. By integrating this technology, Sardine enables businesses to establish a robust risk and fraud management framework, ultimately reducing costs within the fintech ecosystem.

SpinLaunch Inc. is a spaceflight technology development company based in Long Beach, California, founded in 2014. The company specializes in creating an innovative launch system that utilizes a large mass accelerator, or centrifuge, to propel payloads into space without the use of chemical propellants. This kinetic space launch system is designed to enable on-demand launches of small satellites under various weather conditions. By spinning the payload in a vacuum to minimize friction, SpinLaunch aims to achieve speeds of approximately 3,000 miles per hour, allowing objects to be launched directly into space or providing initial thrust for further ascent with supplemental rockets. Through this approach, SpinLaunch seeks to offer a more cost-effective and sustainable alternative to traditional space launch methods.

Vitara Biomedical is focused on developing a therapeutic platform designed to support premature infants. The company draws inspiration from natural physiological processes to improve neonatal care, aiming to enhance the quality of life for these vulnerable newborns. By addressing the unique challenges faced by premature infants, Vitara Biomedical seeks to reduce mortality rates and associated health complications, ultimately providing a foundation for a healthier future for both infants and their families.

Isovalent develops open-source software and enterprise solutions for cloud-native networking, security, and observability. Its flagship product, Cilium, enables enterprises to connect, monitor, and secure workloads in modern environments. Isovalent serves leading global organizations and has offices in Cupertino, CA and Zurich, Switzerland.

Founded in 2016, Lori Systems operates a logistics platform that connects transporters with cargo owners. Based in Nairobi, Kenya, with offices in Mombasa, Kampala, and Lagos, the company uses technology to improve transparency, flexibility, reliability, and cost savings (up to 18%) in Africa's $180 billion annual haulage market.

Founded in 2018, Merlin Labs is based in Boston, Massachusetts. It specializes in developing autonomous flight technology for fixed-wing aircraft, using artificial intelligence and machine learning to enable goods transportation without human pilots.

Courier is a developer of notification management software that enables businesses to efficiently route user notifications across multiple channels, such as email, SMS, and messaging platforms. Its API allows developers to optimize notification delivery by considering various factors, including user engagement history and real-time online status. This flexibility permits the creation of reusable messages that can be tailored for specific channels, ensuring relevant and timely communication. With a strong focus on customer success, Courier has established long-lasting relationships with its clients by continuously adapting to technological advancements and industry changes. The company is committed to maintaining stability in its management while pushing the boundaries of innovation to meet the evolving needs of its customers.

Sesame, Inc., operating as SesameCare, is a healthcare technology company founded in 2018 and based in New York, New York. The company has developed an innovative platform that enables users to book medical appointments and access healthcare services conveniently and affordably. By leveraging an AI-enabled marketplace, SesameCare eliminates the need for health insurance, fostering competition among healthcare providers based on quality, accessibility, and pricing. This approach allows the company to offer Americans high-quality medical care at significantly reduced costs. Additionally, Sesame is recognized as the official telehealth partner of Costco, further enhancing its reach and service offerings.

Wonder is a technology company that develops an all-in-one gaming platform for Android mobile devices. The platform enables users to play, stream, and share games across devices seamlessly.

Nava is a health insurance brokerage based in New York, New York, dedicated to providing high-quality, affordable healthcare solutions to employers and their employees. The company offers a range of services that include healthcare tools, year-round employee advocacy, and continuous evaluation of healthcare plans. By leveraging these resources, Nava empowers clients to deliver essential benefits while simultaneously reducing overall plan costs. Its innovative approach aims to transform the employee benefits landscape through enhanced access and advocacy in healthcare.

FarmWise, established in 2016 and headquartered in San Francisco, specializes in developing and manufacturing robotic machinery for agriculture. The company's primary product is a mechanical weeder, designed to track and remove weeds in vegetable crops, enhancing farm efficiency and reducing herbicide usage. FarmWise also offers comprehensive training and support to ensure optimal use of its technology.

Mirvie is a biotechnology company specializing in precise, non-invasive diagnostic tests for maternal-fetal health. Founded in 2018, the company aims to enhance pregnancy safety by providing actionable insights to families and enabling early intervention for potential complications.

Invetx, Inc. is a biotechnology company based in Boston, Massachusetts, specializing in the development of protein-based therapeutics for animal health care and veterinary medicine. The company employs a team of veterinary scientists and clinicians dedicated to the discovery and development of biotherapeutics for both pets and farm animals. Invetx aims to transform the animal health industry by leveraging biopharmaceutical technologies to improve health outcomes significantly. By combining deep expertise in veterinary science with innovative therapeutic solutions, Invetx seeks to advance the future of animal care, providing effective treatments that cater to the needs of various animal populations.

Aspen Neuroscience develops autologous neuron replacement therapies based on induced pluripotent stem cells to treat neurological conditions, starting with Parkinson's disease. The company uses patient-specific restorative cell therapies by combining pluripotent stem cell biology with genomic approaches and artificial intelligence to address both sporadic and familial forms of Parkinson's disease, focusing on autologous neuron replacement to modify disease progression. Based in San Diego, California, the company is a development-stage biotechnology company pursuing expansion of its iPSC-based platform to other brain disorders.

OMass Therapeutics is a biotechnology company based in Oxford, United Kingdom, that leverages structural mass spectrometry to discover protein-based novel medicines. The company develops a platform that provides access to native mass spectrometry and enables the study of complex protein assemblies and their interactions with biomolecules, allowing biotechnology and pharmaceutical clients to tackle challenging drug targets and biotherapeutics. Through a collaborative framework, OMass Therapeutics supports drug discovery efforts by applying its mass spectrometry technology to identify and characterize potential therapeutic candidates without requiring clients to establish in-house instrumentation and expertise.

Celsius Therapeutics, Inc. is a biotechnology company focused on developing precision medicines for patients suffering from cancer and autoimmune diseases. Founded in 2018 and based in Cambridge, Massachusetts, the company employs a multidisciplinary approach, integrating the expertise of scientists, computational biologists, and clinicians. Celsius Therapeutics utilizes advanced techniques such as single-cell genomic analysis and machine learning to identify and develop innovative therapeutic solutions. By leveraging these cutting-edge technologies, the company aims to create life-changing medicines that address unmet medical needs.

Founded in 2017, Spotlight Therapeutics develops innovative therapeutics based on its targeted active gene editing platform. The company focuses on creating biologics tailored to specific cell populations, with initial programs in immuno-oncology, ophthalmology, and hematology.

Nothing is a consumer electronics company that designs and manufactures smartphones, earbuds, and other connected devices. It aims to remove barriers between people and technology by focusing on product integration and user experience. The company offers mobile devices and personalized noise-cancellation earbuds featuring wireless charging, water resistance, and dual connectivity. Through its innovative approach, Nothing seeks to create a seamless digital ecosystem that combines hardware and software, providing customers with reliable and durable technology at affordable prices.

Redpanda Data is a company that provides a modern streaming data platform designed to handle large data streams effectively. Its platform allows users to record both real-time and historical enterprise data, making it a valuable tool for organizations that require efficient data management. Redpanda's architecture features a compatible application programming interface and is deployable as a single binary, which simplifies the deployment process. Additionally, it includes a built-in schema registry and operates without external dependencies, enhancing performance and reliability for developers. This combination of features enables enterprises to maintain their software stacks while improving data processing capabilities.

Founded in 2017, Censys offers an internet intelligence platform that provides real-time visibility into global networks and devices. Its solution enables businesses to discover unknown assets, monitor remote workforce, identify threat actors, and manage attack surfaces proactively.

Leyden Labs develops a Mucosal Protection Platform to protect against respiratory viruses, including influenza and coronaviruses. The company offers a portfolio of broad protective nasal sprays designed to reduce the risk of infection and limit transmission, aiming to improve public health through innovative protection methods. Its team combines biotechnology veterans with new talent to advance solutions that address common viral threats at the mucosal surface.

Sibros is a technology company that specializes in software-defined vehicle management through its Deep Connected Platform™. This platform integrates real-time data collection, software configuration management, remote updates, and diagnostic commands, all while adhering to stringent automotive safety, security, and data privacy standards. Sibros's solutions are versatile and can be implemented across various vehicle architectures, including legacy gas and diesel engines, next-generation battery electric vehicles, fuel cells, motorcycles, buses, commercial trucks, and heavy machinery. By leveraging advanced technology developed in Silicon Valley, Sibros empowers original equipment manufacturers (OEMs) to enhance customer experiences, reduce costs, and explore new revenue opportunities throughout the entire mobility product life cycle. The company's software manages a vehicle's complete software inventory and configurations, facilitating the delivery of connected vehicle services and personalized mobility solutions at scale.

Founded in London in 2015, InstaDeep develops AI-based decision-making systems for enterprises. Its platform offers advanced pattern recognition, GPU-accelerated insights, self-learning systems, machine learning, and predictive analytics to optimize decisions across manufacturing, logistics, mobility, and energy sectors.

Mill Industries develops and rents smart kitchen bins that chop, dry, shrink, and deodorize food waste overnight, turning it into a coffee‑ground‑like material. The system is digitally connected, allowing users to monitor usage and receive free shipping of the dried residue to a partner facility that converts it into animal feed or compost. By reducing household waste and enabling efficient recycling, the company addresses climate‑related food waste challenges.

Found is dedicated to improving people’s overall wellbeing by making evidence-based weight loss accessible and affordable. The company was founded in 2019 and is headquartered in San Francisco, California, United States.

Founded in London in 2017, Synthesia Ltd. specializes in AI-driven video generation platforms. Its technology transforms text into professional videos with customizable avatars and voiceovers in over 140 languages, enabling efficient creation of personalized advertising, corporate communications, e-learning content, and more.

Universe is an information and technology company that offers a mobile app designed to facilitate the creation of websites, online shops, and portfolios. The platform provides users with electric internet capabilities, enabling them to easily build and manage their digital presence. Additionally, Universe includes a payment block feature that allows users to sell products and process payments online efficiently. To further support commerce, the company offers an order management system, which aids in streamlining financial transactions and enhances the overall customer experience.

Founded in 2017, Upbound develops a multi-cloud platform that enables organizations to treat multiple cloud environments as one. Its platform facilitates automation, cost optimization, capacity management, failover, policy enforcement, and portability across clouds.

Ankyra is a biotech company focused on developing anchored immunotherapy to enhance cancer treatment. The company's innovative approach addresses the challenges associated with traditional cytokine therapeutics, which often face limitations due to widespread immune activation and toxicity when administered systemically. Ankyra utilizes its Anchored Immunotherapy Platform to create ANK-101, a stable complex that combines a modified IL-12 cytokine with an FDA-approved adjuvant, aluminum hydroxide, which helps to retain the cytokine's potent activity at the tumor site. This localized delivery results in targeted inflammation that activates an anti-tumor immune response while minimizing adverse effects. Ankyra aims to optimize the efficacy and safety of its therapies, ultimately improving treatment outcomes for cancer patients.

Infinitus Systems automates phone calls in healthcare using AI. It streamlines administrative tasks like insurance eligibility checks, improving efficiency, reducing costs, and enhancing patient care.

StrongDM, Inc. is a technology company based in Burlingame, California, founded in 2015. The company offers a platform designed to manage and audit access to various databases and servers for employees, vendors, and cloud-based tools. Its services enable organizations to efficiently create and remove users, manage permissions, and ensure proper data handling. StrongDM's platform simplifies the process of controlling access across multiple systems, enhancing security and compliance. In 2016, the company gained recognition as the Audience Favorite at the Strata+Hadoop World conference, highlighting its impact in the data management sector.

ROME Therapeutics, Inc. is a biotechnology company based in Cambridge, Massachusetts, focused on developing innovative therapies for cancer and autoimmune diseases. Founded in 2019, the company utilizes the repeatome, which encompasses extensive segments of genetic material previously regarded as "junk DNA," to identify new drug targets and advance multiple discovery programs. ROME Therapeutics has assembled a team of experts in oncology, immunology, virology, and machine learning to drive its research and development efforts, aiming to harness this uncharted area of biology for effective treatments. Through its work, ROME seeks to provide healthcare professionals with powerful new options for addressing complex medical challenges.

Ultromics Limited, founded in 2017 and based in Oxford, United Kingdom, specializes in developing advanced echocardiography software aimed at enhancing the diagnosis of coronary heart disease. By leveraging artificial intelligence, the company has created highly accurate diagnostic tools that improve the identification of coronary artery disease, achieving diagnostic accuracy improvements of over 90%. Ultromics' technology processes complex data from electrocardiograms, empowering healthcare providers to make informed clinical decisions and ultimately enhancing patient care in cardiology.

Sonoma Biotherapeutics, Inc. is focused on developing adoptive T regulatory (Treg) cell therapies aimed at treating autoimmune and degenerative diseases. Established in 2019 and based in South San Francisco, California, with an additional office in Seattle, the company employs next-generation genome editing and target-specific cell therapy techniques to innovate in the field of Treg cell therapeutics. The firm aims to create disease-modifying and potentially curative therapies that promote self-tolerance and inhibit harmful inflammatory responses associated with conditions such as rheumatoid arthritis, inflammatory bowel disease, multiple sclerosis, amyotrophic lateral sclerosis, and Alzheimer's disease. Founded by experts in Treg biology and cell therapy, Sonoma Biotherapeutics integrates advanced methodologies to enhance its therapeutic offerings.

Prime Medicine is a biotechnology company focused on developing genetic therapies using its innovative Prime Editing technology. This next-generation gene editing method allows for precise "search and replace" modifications in the genome, aimed at restoring normal genetic function. The company targets a wide range of diseases with significant unmet medical needs, leveraging the efficiency and versatility of its gene editing capabilities to address the underlying causes of these conditions. Through its commitment to advancing gene editing, Prime Medicine seeks to transform the landscape of genetic medicine.

Physna LLC, founded in 2015 and based in Cincinnati, Ohio, specializes in developing geometric search engine software tailored for computer-aided design and 3D printing, among other manufacturing processes. The company's innovative platform utilizes proprietary algorithms and advanced geometric deep learning technology to deconstruct 3D files into a structured format, allowing users to search, compare, and analyze 3D models for quality control and automated inspection. Physna's offerings cater to various industries, including aerospace, automotive, defense, consumer goods, and energy, empowering clients to enhance efficiency and productivity in their manufacturing operations. Additionally, Physna owns Thangs.com, a rapidly growing 3D community and search engine, which further contributes to its mission of democratizing access to 3D design and analysis tools, thus fostering innovation in areas such as product design, healthcare, augmented reality, and gaming.

Brightline, Inc. is a pediatric behavioral health care provider that focuses on supporting children and their families through innovative technology and integrated care. Established in 2019 and headquartered in Palo Alto, California, Brightline offers a range of services including behavioral therapy, psychiatry, medication support, speech-language therapy, and occupational therapy. The company emphasizes virtual behavioral health services and a collaborative care team to address the diverse needs of children at various developmental stages. Originally named Emilio Health, Inc., the company rebranded to Brightline in May 2020, reflecting its commitment to delivering accessible and comprehensive behavioral health solutions.

Favor is a direct-to-consumer service for women and people who menstruate, that’s on a mission to make healthcare more accessible by building a digital health platform that closes racial, gender and socioeconomic gaps in our healthcare system. Favor is the easiest way for women and people who menstruate to address their sexual health and overall wellbeing, regardless of where they live or if they’re covered by health insurance–making Favor an affordable, accessible telehealth provider.

PostHog is an open‑source product analytics platform that enables developers to understand how users interact with their applications. The platform automatically captures events, provides visual analytics, filtering, group analysis, session recordings, funnels, feature flags, and experimentation tools. It integrates with monitoring services and supports testing and deployment of new features. Founded in 2020, the company is headquartered in San Francisco.

Founded in 2018, Merlin Labs is based in Boston, Massachusetts. It specializes in developing autonomous flight technology for fixed-wing aircraft, using artificial intelligence and machine learning to enable goods transportation without human pilots.

Overture Life, Inc. is a biotechnology company based in New York, established in 2017, that specializes in developing robotic solutions for in vitro fertilization (IVF) applications. The company focuses on automating the IVF process through innovative medical devices and embryo testing methodologies, which enhance the efficiency and success rates of fertility treatments. By optimizing resource use and lowering costs, Overture Life aims to make IVF more accessible to a broader audience. Its technology includes automated cryopreservation and embryo testing services, enabling fertility clinics to identify viable embryos prior to implantation, thereby improving patient outcomes and supporting individuals in their journey to parenthood.

OneNav develops a mobile positioning system for smartphones, wearables, and IoT devices. It leverages the modernized L5 signaling band from navigation satellite constellations to deliver accurate and reliable tracking services.

Smol is a homecare startup specializing in the delivery of eco-friendly laundry capsules and dishwasher tablets directly to customers' homes via subscription. The company's products are designed to fit through standard letterboxes, offering convenience and cost savings compared to leading brands. Smol's offerings are vegan-friendly, free from animal testing and derivatives, and packaged in recycled and recyclable materials, aligning with environmentally conscious consumer preferences.

Headway is a leading data-driven media buying company for marketers. It integrates innovative technology with partner platforms to deliver smart cross-channel services, making ads more relevant and driving consumer engagement.

Affinia Therapeutics develops adeno-associated virus (AAV) gene therapies for muscular and central nervous system diseases. The company uses an AAV vector design platform built on synthetic and systems biology, high-throughput screening, and tissue- and single-cell-resolution analyses to create vectors with improved properties. It leverages sequencing, artificial intelligence, and structural modeling to enable rational design of therapies. Headquartered in Waltham, Massachusetts, Affinia Therapeutics was founded in 2019 and targets diseases with significant unmet needs in muscle and CNS.

AWB BioTech uses data from preclinical and clinical studies to guide a drug’s effect on patients.

Outlier is an online education platform that offers intro-level college courses online at a relatively affordable price. Their courses employ engaging content and cutting-edge educational technology to create an immersive, student-friendly learning experience. Outlier is reimagining higher education as a resource that is accessible, equitable, and affordable for everyone.

Ventus Therapeutics is a biopharmaceutical company focused on discovering and developing innovative small molecule medicines that target the innate immune system. The company employs a structural immunology platform that provides deep insights into molecular structures and mechanisms, enabling precise targeting of the innate immune system. Ventus combines advanced protein engineering capabilities with cutting-edge rational and structure-based drug design tools to create therapeutics aimed at treating autoimmune diseases, inflammatory conditions, and cancer. The company is actively building a diverse pipeline of drug programs that address significant targets within the innate immune system, with the goal of advancing treatments for both acute and chronic inflammatory and immune-related diseases.

Snorkel AI, Inc. is a technology company that specializes in developing an end-to-end machine-learning platform designed to facilitate the creation, management, and monitoring of AI applications. Founded in 2016 and based in Palo Alto, California, the company offers Snorkel Flow, a platform that enables programmatic data labeling, augmentation, and curation. This platform supports the clean integration and management of data for AI, as well as the training and deployment of various models. Snorkel AI's technology is particularly adept at extracting entities, relationships, and structured information from complex documents and forms, while also ranking content based on relevance and other factors. The company serves diverse sectors, including finance, government, telecommunications, insurance, healthcare, and e-commerce, and is recognized for its contributions to AI research through peer-reviewed publications.

Founded in 2017 and based in Boston, Lightmatter is an artificial intelligence hardware company that specializes in integrated optical technology. It designs photonic chips to enable data processing and communication through light signals, aiming to improve efficiency and scalability for AI data centers.

Genesis Global Technology Limited specializes in developing custom software and solutions tailored for the capital markets. Founded in 2015 and headquartered in London, with an additional office in New York, the company provides a range of platforms designed to enhance trading and operational efficiency. Its offerings include an automated quoting system for managing requests for quotes, an order execution management system, and a trade allocation manager that facilitates various trading processes. Additionally, Genesis Global offers tools for data management and reconciliation, such as a short/long code manager and a matcher. The company is led by a team of industry veterans with substantial experience in trading technologies across multiple asset classes, aiming to deliver innovative solutions that align with the evolving needs of clients in the financial sector.

Dandelion Energy, Inc. is a Palo Alto, California-based company founded in 2017 that specializes in affordable geothermal heating and cooling solutions. The company replaces traditional air conditioning and heating systems with an innovative home geothermal system that utilizes a powerful heat pump and underground pipes to transfer heat between the earth and the residence. This system is designed to harness thermal energy from below the earth's surface to regulate indoor temperatures and provide hot water, allowing homeowners to transition from conventional heating fuels to a more sustainable geothermal alternative. Dandelion Energy is committed to making renewable heating and cooling accessible and cost-effective for homeowners.

Verve Therapeutics is a biotechnology company developing genetic medicines for cardiovascular disease, aiming to transform treatment from chronic management to single-course gene editing therapies. It leverages human genetics analysis and gene-editing technology, with expertise in cardiovascular medicine, human genetics, gene editing, delivery technologies, drug development, and commercialization.

Multiverse is a tech startup that provides an alternative to traditional university training by offering career-focused apprenticeships and an upskilling platform. It helps young people access practical, high-quality learning and supports businesses in accelerating AI adoption and workforce skills in data and technology through expert-guided, AI-powered coaching and personalized on-the-job learning, leading to measurable productivity improvements.

EQRx, Inc. is a biotechnology company based in Cambridge, Massachusetts, established in 2019. The company focuses on re-engineering the drug discovery and delivery process to provide a market-based solution to the escalating costs of medications. EQRx aims to enhance the efficiency and affordability of high-quality, patent-protected medicines by collaborating with various stakeholders across the healthcare system and leveraging advancements in science and technology. The company has developed a robust pipeline with over ten programs, including clinical and preclinical projects targeting oncology and immune-inflammatory conditions, featuring compounds such as Aumolertinib, Lerociclib, Sugemalimab, and Nofazinlimab.

LifeMine Therapeutics, Inc. is a biotechnology company focused on the genomic discovery of new drug modalities derived from eukaryotic microbes, specifically fungi. Founded in 2016 and headquartered in Cambridge, Massachusetts, with an additional office in New York, it employs an integrated drug discovery platform that combines genomics, artificial intelligence, and synthetic biology. LifeMine’s Avatar-Rx platform utilizes high-throughput microbiology, data science, genome engineering, and automation technologies to identify novel gene-encoded molecules (GEMs) with specific biological functions. The company emphasizes chemoinformatic-assisted drug optimization and advanced chemical synthesis, enabling the progression of new product candidates into development. Founded by experts in the field, LifeMine Therapeutics aims to innovate medicine through its unique approach to leveraging the fungal biosphere.

AMP Robotics Corporation specializes in designing and manufacturing robotic systems for material recovery facilities and recycling operations, focusing on automating the identification, sorting, and processing of complex waste streams. The company's flagship product, AMP Cortex, utilizes advanced robotics and computer vision technology to efficiently pick and sort recyclable materials, significantly lowering sorting costs. Additionally, AMP Neuron, a software solution, captures and analyzes material data to identify features in a manner similar to human perception. By leveraging artificial intelligence and machine learning, AMP Robotics enhances recycling processes for various waste types, including municipal solid waste and e-waste. The modular design of its systems allows for easy integration into existing infrastructure, minimizing disruption and capital investment. Founded in 2014 and headquartered in Louisville, Colorado, AMP Robotics has formed strategic partnerships to further its mission of improving recycling rates and economic recovery of recyclables.

Vercel develops a cloud platform for on-demand deployment of frontend applications. It offers automated deployment solutions from GitHub, Bitbucket, and GitLab pull/merge requests. Vercel also provides services for developing, previewing, and shipping Jamstack sites.

Locanabio is a biotechnology company developing RNA-targeted gene therapies for underserved diseases, with a focus on neuromuscular, neurodegenerative, and retinal conditions. It employs an RNA-targeting platform to modify disease-causing RNA and correct aberrant transcripts, offering therapies distinct from DNA-based approaches. The company identifies target RNA sequences within transcripts and programs therapies to advance candidates for rare genetic neuromuscular, neurodegenerative, and retinal diseases. Located in San Diego, Locanabio aims to translate RNA-directed interventions into treatments for patients with severe conditions.

Founded in 2008, Hodinkee is a leading online platform dedicated to the world of watches. It offers comprehensive reviews, news, and historical insights on timepieces, along with an e-boutique selling vintage watches, straps, menswear accessories, and other watch-related products. Hodinkee also operates pop-up shops in the United States.

National Resilience, also known as Resilience, is a biopharmaceutical manufacturing and technology company that provides end-to-end manufacturing and development solutions for diverse modalities, including cell and gene therapies, viral vectors, vaccines, and proteins. It actively invests in developing new manufacturing technologies to expand access to complex medicines and supports partners through the full lifecycle from development to commercial supply. The company was incorporated in 2020 and is based in La Jolla, California.

Factory OS, Inc. designs, manufactures, and sells modular re-locatable apartment buildings and residential homes, specializing in off-site construction. Established in 2017 and headquartered in Vallejo, California, the company offers a wide range of modular solutions, including multi-family residential homes, prefabricated townhouses, modular apartments, and various commercial structures such as office buildings and retail locations. Factory OS employs an integrated and tech-enabled approach to streamline the housing development process, focusing on reducing waste, controlling energy consumption, and enhancing building efficiency. The company is committed to innovation through an active research and development program that incorporates advancements in design, technology, and construction methods.

Invivyd is a commercial-stage biopharmaceutical company dedicated to developing and commercializing antibody-based therapies aimed at protecting individuals from serious viral infectious diseases, particularly those with pandemic potential. The company focuses on innovative solutions that surpass the natural limits of immunity, starting with its lead product candidates for SARS-CoV-2. Notable among these candidates are ADG20, designed for the treatment and prevention of COVID-19, and VYD222, a monoclonal antibody optimized for enhanced potency and durability of protection. Invivyd's mission centers on delivering effective, long-lasting therapies to safeguard vulnerable populations from the severe repercussions of ongoing viral threats.